Clinical Trials Directory

Trials / Terminated

TerminatedNCT00920322

Repetitive Transcranial Magnetic Stimulation (rTMS) in Depression

A Randomised Study of rTMS in Depression

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Northside Clinic, Australia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will report on the outcomes of rTMS administered 3 times per week, compared with the standard protocol of 5 times per week. Participants will be randomly assigned to frequency condition and depressive symptomatology will be measured weekly using a range of clinician and self-rated questionnaires. Participants will remain in the study for at least 4 weeks, with the option of continuing for a further 2 weeks as judged by the study psychiatrist. It is hypothesised that rTMS administered three times per week will be equally as effective as rTMS administered five times per week in reducing depressive symptomatology.

Detailed description

Numerous studies have demonstrated the efficacy of active rTMS over sham rTMS for depression; however, few have systematically studied the optimal frequency of treatment sessions to achieve this efficacy. To date, the majority of studies have administered rTMS every weekday, although this approach has not been widely contested. In addition, most studies have only assessed the effectiveness of rTMS over a two week period, which has resulted in some improvement in depressive symptomatology; however, a longer treatment course would likely result in greater improvement. In this study depressed patients will be randomly assigned to receive rTMS either 3 or 5 times per week, for a period of 4-6 weeks. A range of rating scales will be used to assess the improvement of depressive symptomatology within and between the two frequency groups, to ultimately determine whether TMS is needed 5 times per week to achieve adequate anti-depressant effects or whether 3 times per week is sufficient in achieving a similar level of efficacy for patients.

Conditions

Interventions

TypeNameDescription
DEVICErTMS 5 x weeklyPatients will receive rTMS five times weekly for 4 weeks
DEVICErTMS 3 times weeklyPatients will receive rTMS 3 times weekly for 4 weeks

Timeline

Start date
2009-05-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2009-06-15
Last updated
2011-07-21

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00920322. Inclusion in this directory is not an endorsement.